ウシ血漿誘導体のグローバル及び中国市場インサイト・予測(~2027年)

QYResearchが発行した調査報告書(QY21CN0467)
◆英語タイトル:Global and China Bovine Blood Plasma Derivatives Market Insights, Forecast to 2027
◆商品コード:QY21CN0467
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月28日(※2024年版があります。お問い合わせください。)
◆ページ数:162
◆レポート形式:英語 / PDF
◆納品方法:Eメール(24時間以内)
◆調査対象地域:グローバル、中国
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートではグローバルにおけるウシ血漿誘導体の市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ウシ血漿誘導体の種類別市場規模(ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他)、用途別市場規模(科学研究、工業生産、飼料、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のウシ血漿誘導体市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるウシ血漿誘導体の種類別市場規模(2016年-2027年):ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他
・世界におけるウシ血漿誘導体の用途別市場規模(2016年-2027年):科学研究、工業生産、飼料、その他
・ウシ血漿誘導体の中国市場分析
- ウシ血漿誘導体の中国市場規模(2016年-2027年)
- 中国におけるウシ血漿誘導体の主要プレイヤー別市場シェア
- 中国におけるウシ血漿誘導体の種類別市場規模:ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他
- 中国におけるウシ血漿誘導体の用途別市場規模:科学研究、工業生産、飼料、その他
・ウシ血漿誘導体の北米市場(2016年-2027年)
・ウシ血漿誘導体のヨーロッパ市場(2016年-2027年)
・ウシ血漿誘導体のアジア太平洋市場(2016年-2027年)
・ウシ血漿誘導体の中南米市場(2016年-2027年)
・ウシ血漿誘導体の中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Thermo Fisher、GE Healthcare、Merck (Sigma-Aldrich)、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、VWR、Corning、Serana、Lanzhou Minhai、Zhejiang Tianhang Biotechnology、ExCell Bio、Jin Yuan Kang、American Protein Company、Sonac
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...
【レポートの概要】

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.
In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.

Market Analysis and Insights: Global and China Bovine Blood Plasma Derivatives Market
This report focuses on global and China Bovine Blood Plasma Derivatives market.
In 2020, the global Bovine Blood Plasma Derivatives market size was US$ 1802 million and it is expected to reach US$ 2912.4 million by the end of 2027, with a CAGR of 7.2% during 2021-2027. In China the Bovine Blood Plasma Derivatives market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Bovine Blood Plasma Derivatives Scope and Market Size
Bovine Blood Plasma Derivatives market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Bovine Blood Plasma Derivatives market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other

Segment by Application
Scientific Research
Industrial Production
Feed
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac

【レポートの目次】

1 Study Coverage
1.1 Bovine Blood Plasma Derivatives Product Introduction
1.2 Market by Type
1.2.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Type
1.2.2 Bovine Serum
1.2.3 FBS
1.2.4 Bovine Serum Albumin
1.2.5 Fibrinogen
1.2.6 Protein Ingredient
1.2.7 Other
1.3 Market by Application
1.3.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Application
1.3.2 Scientific Research
1.3.3 Industrial Production
1.3.4 Feed
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Bovine Blood Plasma Derivatives Market Size, Estimates and Forecasts
2.1.1 Global Bovine Blood Plasma Derivatives Revenue 2016-2027
2.1.2 Global Bovine Blood Plasma Derivatives Sales 2016-2027
2.2 Global Bovine Blood Plasma Derivatives, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Bovine Blood Plasma Derivatives Historical Market Size by Region (2016-2021)
2.3.1 Global Bovine Blood Plasma Derivatives Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Bovine Blood Plasma Derivatives Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Bovine Blood Plasma Derivatives Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Region (2022-2027)
2.4.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2022-2027)

3 Global Bovine Blood Plasma Derivatives Competitor Landscape by Players
3.1 Global Top Bovine Blood Plasma Derivatives Manufacturers by Sales
3.1.1 Global Bovine Blood Plasma Derivatives Sales by Manufacturer (2016-2021)
3.1.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Bovine Blood Plasma Derivatives Manufacturers by Revenue
3.2.1 Key Bovine Blood Plasma Derivatives Manufacturers Covered: Ranking by Revenue
3.2.2 Global Bovine Blood Plasma Derivatives Revenue by Manufacturers (2016-2021)
3.2.3 Global Bovine Blood Plasma Derivatives Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Bovine Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Bovine Blood Plasma Derivatives Revenue in 2020
3.2.6 Global Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Bovine Blood Plasma Derivatives Price by Manufacturers
3.4 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution, Product Types
3.4.1 Bovine Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bovine Blood Plasma Derivatives Product Type
3.4.3 Date of International Manufacturers Enter into Bovine Blood Plasma Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Bovine Blood Plasma Derivatives Market Size by Type (2016-2021)
4.1.1 Global Bovine Blood Plasma Derivatives Sales by Type (2016-2021)
4.1.2 Global Bovine Blood Plasma Derivatives Revenue by Type (2016-2021)
4.1.3 Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Bovine Blood Plasma Derivatives Market Size Forecast by Type (2022-2027)
4.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Type (2022-2027)
4.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Type (2022-2027)
4.2.3 Bovine Blood Plasma Derivatives Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Bovine Blood Plasma Derivatives Market Size by Application (2016-2021)
5.1.1 Global Bovine Blood Plasma Derivatives Sales by Application (2016-2021)
5.1.2 Global Bovine Blood Plasma Derivatives Revenue by Application (2016-2021)
5.1.3 Bovine Blood Plasma Derivatives Price by Application (2016-2021)
5.2 Bovine Blood Plasma Derivatives Market Size Forecast by Application (2022-2027)
5.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Application (2022-2027)
5.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Application (2022-2027)
5.2.3 Global Bovine Blood Plasma Derivatives Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
6.1.1 China Bovine Blood Plasma Derivatives Sales YoY Growth 2016-2027
6.1.2 China Bovine Blood Plasma Derivatives Revenue YoY Growth 2016-2027
6.1.3 China Bovine Blood Plasma Derivatives Market Share in Global Market 2016-2027
6.2 China Bovine Blood Plasma Derivatives Market Size by Players (International and Local Players)
6.2.1 China Top Bovine Blood Plasma Derivatives Players by Sales (2016-2021)
6.2.2 China Top Bovine Blood Plasma Derivatives Players by Revenue (2016-2021)
6.3 China Bovine Blood Plasma Derivatives Historic Market Review by Type (2016-2021)
6.3.1 China Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
6.3.2 China Bovine Blood Plasma Derivatives Revenue Market Share by Type (2016-2021)
6.3.3 China Bovine Blood Plasma Derivatives Price by Type (2016-2021)
6.4 China Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Bovine Blood Plasma Derivatives Sales Forecast by Type (2022-2027)
6.4.2 China Bovine Blood Plasma Derivatives Revenue Forecast by Type (2022-2027)
6.4.3 China Bovine Blood Plasma Derivatives Price Forecast by Type (2022-2027)
6.5 China Bovine Blood Plasma Derivatives Historic Market Review by Application (2016-2021)
6.5.1 China Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
6.5.2 China Bovine Blood Plasma Derivatives Revenue Market Share by Application (2016-2021)
6.5.3 China Bovine Blood Plasma Derivatives Price by Application (2016-2021)
6.6 China Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Bovine Blood Plasma Derivatives Sales Forecast by Application (2022-2027)
6.6.2 China Bovine Blood Plasma Derivatives Revenue Forecast by Application (2022-2027)
6.6.3 China Bovine Blood Plasma Derivatives Price Forecast by Application (2022-2027)

7 North America
7.1 North America Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
7.2 North America Bovine Blood Plasma Derivatives Market Facts & Figures by Country
7.2.1 North America Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
7.2.2 North America Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
8.2 Asia Pacific Bovine Blood Plasma Derivatives Market Facts & Figures by Region
8.2.1 Asia Pacific Bovine Blood Plasma Derivatives Sales by Region (2016-2021)
8.2.2 Asia Pacific Bovine Blood Plasma Derivatives Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
9.2 Europe Bovine Blood Plasma Derivatives Market Facts & Figures by Country
9.2.1 Europe Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
9.2.2 Europe Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
10.2 Latin America Bovine Blood Plasma Derivatives Market Facts & Figures by Country
10.2.1 Latin America Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
10.2.2 Latin America Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Bovine Blood Plasma Derivatives Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Bovine Blood Plasma Derivatives Market Facts & Figures by Country
11.2.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2016-2021)
11.2.2 Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Description and Business Overview
12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Description and Business Overview
12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GE Healthcare Bovine Blood Plasma Derivatives Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Merck (Sigma-Aldrich)
12.3.1 Merck (Sigma-Aldrich) Corporation Information
12.3.2 Merck (Sigma-Aldrich) Description and Business Overview
12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Products Offered
12.3.5 Merck (Sigma-Aldrich) Recent Development
12.4 Moregate BioTech
12.4.1 Moregate BioTech Corporation Information
12.4.2 Moregate BioTech Description and Business Overview
12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Products Offered
12.4.5 Moregate BioTech Recent Development
12.5 Gemini
12.5.1 Gemini Corporation Information
12.5.2 Gemini Description and Business Overview
12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Gemini Bovine Blood Plasma Derivatives Products Offered
12.5.5 Gemini Recent Development
12.6 Atlanta Biologicals
12.6.1 Atlanta Biologicals Corporation Information
12.6.2 Atlanta Biologicals Description and Business Overview
12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Products Offered
12.6.5 Atlanta Biologicals Recent Development
12.7 Tissue Culture Biologicals
12.7.1 Tissue Culture Biologicals Corporation Information
12.7.2 Tissue Culture Biologicals Description and Business Overview
12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Products Offered
12.7.5 Tissue Culture Biologicals Recent Development
12.8 Bovogen
12.8.1 Bovogen Corporation Information
12.8.2 Bovogen Description and Business Overview
12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bovogen Bovine Blood Plasma Derivatives Products Offered
12.8.5 Bovogen Recent Development
12.9 Biowest
12.9.1 Biowest Corporation Information
12.9.2 Biowest Description and Business Overview
12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biowest Bovine Blood Plasma Derivatives Products Offered
12.9.5 Biowest Recent Development
12.10 Internegocios
12.10.1 Internegocios Corporation Information
12.10.2 Internegocios Description and Business Overview
12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Internegocios Bovine Blood Plasma Derivatives Products Offered
12.10.5 Internegocios Recent Development
12.11 Thermo Fisher
12.11.1 Thermo Fisher Corporation Information
12.11.2 Thermo Fisher Description and Business Overview
12.11.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
12.11.5 Thermo Fisher Recent Development
12.12 Biological Industries
12.12.1 Biological Industries Corporation Information
12.12.2 Biological Industries Description and Business Overview
12.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biological Industries Products Offered
12.12.5 Biological Industries Recent Development
12.13 VWR
12.13.1 VWR Corporation Information
12.13.2 VWR Description and Business Overview
12.13.3 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.13.4 VWR Products Offered
12.13.5 VWR Recent Development
12.14 Corning
12.14.1 Corning Corporation Information
12.14.2 Corning Description and Business Overview
12.14.3 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Corning Products Offered
12.14.5 Corning Recent Development
12.15 Serana
12.15.1 Serana Corporation Information
12.15.2 Serana Description and Business Overview
12.15.3 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Serana Products Offered
12.15.5 Serana Recent Development
12.16 Lanzhou Minhai
12.16.1 Lanzhou Minhai Corporation Information
12.16.2 Lanzhou Minhai Description and Business Overview
12.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Lanzhou Minhai Products Offered
12.16.5 Lanzhou Minhai Recent Development
12.17 Zhejiang Tianhang Biotechnology
12.17.1 Zhejiang Tianhang Biotechnology Corporation Information
12.17.2 Zhejiang Tianhang Biotechnology Description and Business Overview
12.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zhejiang Tianhang Biotechnology Products Offered
12.17.5 Zhejiang Tianhang Biotechnology Recent Development
12.18 ExCell Bio
12.18.1 ExCell Bio Corporation Information
12.18.2 ExCell Bio Description and Business Overview
12.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.18.4 ExCell Bio Products Offered
12.18.5 ExCell Bio Recent Development
12.19 Jin Yuan Kang
12.19.1 Jin Yuan Kang Corporation Information
12.19.2 Jin Yuan Kang Description and Business Overview
12.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Jin Yuan Kang Products Offered
12.19.5 Jin Yuan Kang Recent Development
12.20 American Protein Company
12.20.1 American Protein Company Corporation Information
12.20.2 American Protein Company Description and Business Overview
12.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.20.4 American Protein Company Products Offered
12.20.5 American Protein Company Recent Development
12.21 Sonac
12.21.1 Sonac Corporation Information
12.21.2 Sonac Description and Business Overview
12.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Sonac Products Offered
12.21.5 Sonac Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Bovine Blood Plasma Derivatives Industry Trends
13.2 Bovine Blood Plasma Derivatives Market Drivers
13.3 Bovine Blood Plasma Derivatives Market Challenges
13.4 Bovine Blood Plasma Derivatives Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bovine Blood Plasma Derivatives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Thermo Fisher、GE Healthcare、Merck (Sigma-Aldrich)、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、VWR、Corning、Serana、Lanzhou Minhai、Zhejiang Tianhang Biotechnology、ExCell Bio、Jin Yuan Kang、American Protein Company、Sonac

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ウシ血漿誘導体のグローバル及び中国市場インサイト・予測(~2027年)(Global and China Bovine Blood Plasma Derivatives Market Insights, Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。